It may not have been pretty, but Regulus Therapeutics ($RGLS) raised close to $81 million from its recent IPO and some related transactions. And the company did it with a big assist from some major league partners in the biopharma industry. Report
| Tuesday, June 23 | 11:00am ET / 8:00am PT | Presented By: MWV Healthcare
This webinar will address the impact of medication non-adherence in clinical trials. Accurate adherence measurement is necessary to evaluate a compound's true potential and increase the likelihood of a successful trial outcome. Register today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!